Objective: This study was designed to detect the changes of serum soluble Fas (sFas) levels in patients with locally advanced unresectable rectal cancer (LAURC),and to explore its prognostic value of response.Methods:...Objective: This study was designed to detect the changes of serum soluble Fas (sFas) levels in patients with locally advanced unresectable rectal cancer (LAURC),and to explore its prognostic value of response.Methods: Soluble samples were obtained from LAURC subjects,treated by concurrent chemoradiotherapy,before treatment and one month after treatment.Healthy donor serum samples were used as controls.sFas concentration was measured by enzyme-linked immunosorbent assay (ELISA).Results: The sFas levels before treatment and one month after treatment were both significantly higher in LAURC subjects than in healthy controls [(8.79±1.39) and (7.74±1.32) vs.(5.53±1.13) ng/L,P<0.01].The sFas levels before treatment and one month after treatment were significantly lower in the response group (complete and partial responses) than in the non-response group (stable and progressive diseases) [(8.50±1.25) vs.(10.17±1.26) ng/L,P<0.01 and (7.50±1.24) vs.(8.90±1.13) ng/L,P<0.01,respectively].The one-year survival rate was 54.2% and 82.6% in those with sFas levels >8.79 ng/L and <8.79 ng/L before treatment (P<0.02),respectively,50.0% and 87.0% in those with sFas levels >7.74 ng/L and <7.74 ng/L one month after treatment (P<0.01),respectively.Conclusions: The sFas level is higher in LAURC subjects than in healthy controls.Concurrent chemoradiotherapy can reduce sFas levels in LAURC patients.The monitoring of sFas may provide prognostic information for LAURC patients.展开更多
The following letter to the editor highlights the review titled“Liquid biopsy in cholangiocarcinoma:Current status and future perspective”in World J Gastrointest Oncol 2021;13:332-350.It is necessary to realize indi...The following letter to the editor highlights the review titled“Liquid biopsy in cholangiocarcinoma:Current status and future perspective”in World J Gastrointest Oncol 2021;13:332-350.It is necessary to realize individualized therapy to improve the clinical prognosis of patients with cholangiocarcinoma.展开更多
Liver cancer is one of the most common cancers in the world. Of all types of livercancer, hepatocellular carcinoma (HCC) is known to be the most frequent primaryliver malignancy and has seriously compromised the healt...Liver cancer is one of the most common cancers in the world. Of all types of livercancer, hepatocellular carcinoma (HCC) is known to be the most frequent primaryliver malignancy and has seriously compromised the health status of the generalpopulation. Locoregional thermal ablation techniques such as radiofrequency andmicrowave ablation, have attracted attention in clinical practice as an alternativestrategy for HCC treatment. However, their aggressive thermal effect may causeundesirable complications such as hepatic decompensation, hemorrhage, bile ductinjury, extrahepatic organ injuries, and skin burn. In recent years, photodynamictherapy (PDT), a gentle locoregional treatment, has attracted attention in ablationtherapy for patients with superficial or luminal tumors as an alternative treatmentstrategy. However, some inherent defects and extrinsic factors of PDT havelimited its use in clinical practice for deep-seated HCC. In this contribution, theaim is to summarize the current status and challenges of PDT in HCC treatmentand provide potential strategies to overcome these deficiencies in further clinicaltranslational practice.展开更多
文摘Objective: This study was designed to detect the changes of serum soluble Fas (sFas) levels in patients with locally advanced unresectable rectal cancer (LAURC),and to explore its prognostic value of response.Methods: Soluble samples were obtained from LAURC subjects,treated by concurrent chemoradiotherapy,before treatment and one month after treatment.Healthy donor serum samples were used as controls.sFas concentration was measured by enzyme-linked immunosorbent assay (ELISA).Results: The sFas levels before treatment and one month after treatment were both significantly higher in LAURC subjects than in healthy controls [(8.79±1.39) and (7.74±1.32) vs.(5.53±1.13) ng/L,P<0.01].The sFas levels before treatment and one month after treatment were significantly lower in the response group (complete and partial responses) than in the non-response group (stable and progressive diseases) [(8.50±1.25) vs.(10.17±1.26) ng/L,P<0.01 and (7.50±1.24) vs.(8.90±1.13) ng/L,P<0.01,respectively].The one-year survival rate was 54.2% and 82.6% in those with sFas levels >8.79 ng/L and <8.79 ng/L before treatment (P<0.02),respectively,50.0% and 87.0% in those with sFas levels >7.74 ng/L and <7.74 ng/L one month after treatment (P<0.01),respectively.Conclusions: The sFas level is higher in LAURC subjects than in healthy controls.Concurrent chemoradiotherapy can reduce sFas levels in LAURC patients.The monitoring of sFas may provide prognostic information for LAURC patients.
基金Wuhan Municipal Health Commission,No.WX14B22National Natural Science Foundation of China,No.81874208 and No.81700425.
文摘The following letter to the editor highlights the review titled“Liquid biopsy in cholangiocarcinoma:Current status and future perspective”in World J Gastrointest Oncol 2021;13:332-350.It is necessary to realize individualized therapy to improve the clinical prognosis of patients with cholangiocarcinoma.
基金the Wuhan Municipal Health Commission,No.WX14B22the National Natural Science Foundation of China,No.81874208 and No.81700425.
文摘Liver cancer is one of the most common cancers in the world. Of all types of livercancer, hepatocellular carcinoma (HCC) is known to be the most frequent primaryliver malignancy and has seriously compromised the health status of the generalpopulation. Locoregional thermal ablation techniques such as radiofrequency andmicrowave ablation, have attracted attention in clinical practice as an alternativestrategy for HCC treatment. However, their aggressive thermal effect may causeundesirable complications such as hepatic decompensation, hemorrhage, bile ductinjury, extrahepatic organ injuries, and skin burn. In recent years, photodynamictherapy (PDT), a gentle locoregional treatment, has attracted attention in ablationtherapy for patients with superficial or luminal tumors as an alternative treatmentstrategy. However, some inherent defects and extrinsic factors of PDT havelimited its use in clinical practice for deep-seated HCC. In this contribution, theaim is to summarize the current status and challenges of PDT in HCC treatmentand provide potential strategies to overcome these deficiencies in further clinicaltranslational practice.
